Listed by the USPTO as WORSHAM, JESSICA N
Tech Center 1600 • Art Units: 1615
This examiner grants 57% of resolved cases
WORSHAM, JESSICA N works in Tech Center 1600 and Art Unit 1615. The record includes 753 resolved cases, a 56.6% allowance rate, a 56.4% interview lift, and a median of 1082 days to allowance. The interview measure is highly favorable in this record, making interviews a significant consideration for prosecution planning. The allowance rate also shows that interview preparation should be paired with claim amendments and written argument directed to the identified rejection.
The leading companies are Harmony Foods LLC, The Procter & Gamble Company, and Massachusetts Institute of Technology. The leading firms are BakerHostetler, BIRCH STEWART KOLASCH & BIRCH, LLP, and SUGHRUE MION, PLLC. The applicant mix spans food, consumer products, and research. Practitioners may find value in using interviews to explain technical distinctions before committing to unnecessarily narrow claim language.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18714142 | POLY(BETA-AMINO ESTER) MICROPARTICLES FOR MICRONUTRIENT FORTIFICATION | Non-Final OA | Massachusetts Institute of Technology |
| 19209980 | PERSONAL CARE COMPOSITION SUBSTANTIALLY FREE OF ALKYL SULFATE OR ALKYL ETHER SULFATE TYPE OF SURFACTANTS | Non-Final OA | The Procter & Gamble Company |
| 18888534 | STRUCTURED RHEOLOGICAL SOLID PERSONAL CARE COMPOSITION | Non-Final OA | The Procter & Gamble Company |
| 19397956 | TREATMENT OF BLOOD LOSS AT TISSUE WOUND | Final Rejection | P Tech, LLC |
| 18560900 | SEED TREATMENT COMPOSITIONS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18684728 | DIRECT TABLETING AUXILIARY COMPOSITION | Non-Final OA | BASF SE |
| 18879145 | DISPERSION AND COSMETIC CONTAINING SAME | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18741628 | METHODS OF FORMING STORAGE STABLE MIXTURES | Non-Final OA | DSM IP Assets B.V. |
| 18034969 | NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT | Final Rejection | Purdue Research Foundation |
| 18865572 | PLANT DISEASE CONTROL METHOD | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18849372 | Lipid Based Nanoparticles for Targeted Gene Delivery to the Brain | Non-Final OA | National Research Council of Canada |
| 17999347 | EPITHELIAL CANCER THERAPEUTIC AGENT | Non-Final OA | OSAKA UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.6% of resolved applications examined by Jessica N Worsham were allowed (753 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +56.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jessica N Worsham took 1,082 days on average from filing to allowance.
Jessica N Worsham examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
